{"transactions":[{"id":724985,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:15:24.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":115000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001429931-26-000002","document":"form4-06292026_080620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000142993126000002/form4-06292026_080620.xml","form_type":"4"}},{"id":1119009,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:14:28.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":93000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001415889-25-016230","document":"form4-06092025_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016230/form4-06092025_080623.xml","form_type":"4"}},{"id":1478177,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:13:19.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":93000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001415889-24-017161","document":"form4-06172024_080615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017161/form4-06172024_080615.xml","form_type":"4"}},{"id":1850847,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2023-06-20T20:14:03.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 15, 2024 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":92000,"derivative":{"exercise_price":36.87,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001415889-23-010041","document":"form4-06202023_080658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588923010041/form4-06202023_080658.xml","form_type":"4"}},{"id":2091705,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2022-12-09T21:07:21.000Z","date":"2022-12-07","kind":"exercise","acquired":false,"shares":16860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":43140,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":16860},"source":{"system":"sec-edgar","filing":"0001415889-22-012301","document":"form4-12092022_091203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922012301/form4-12092022_091203.xml","form_type":"4"}},{"id":2091704,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VP & CSO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2022-12-09T21:07:21.000Z","date":"2022-12-07","kind":"sale","acquired":false,"shares":16860,"price":36.9283,"value":622611.138,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.69 to $37.28 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":7357,"source":{"system":"sec-edgar","filing":"0001415889-22-012301","document":"form4-12092022_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922012301/form4-12092022_091203.xml","form_type":"4"}},{"id":2091703,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VP & CSO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2022-12-09T21:07:21.000Z","date":"2022-12-07","kind":"exercise","acquired":true,"shares":16860,"price":2.78,"value":46870.8,"ownership":{"direct":true},"balance_after":24217,"source":{"system":"sec-edgar","filing":"0001415889-22-012301","document":"form4-12092022_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922012301/form4-12092022_091203.xml","form_type":"4"}},{"id":2229177,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2022-06-17T20:11:10.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":91000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":91000,"derivative":{"exercise_price":22.48,"exercise_date":"2023-06-16","expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":91000},"source":{"system":"sec-edgar","filing":"0001415889-22-006712","document":"form4-06172022_010651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922006712/form4-06172022_010651.xml","form_type":"4"}},{"id":2662447,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-06-21T20:26:46.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":91000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":91000,"derivative":{"exercise_price":28,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":91000},"source":{"system":"sec-edgar","filing":"0001179110-21-006904","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021006904/edgar.xml","form_type":"4"}},{"id":3104879,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-06-19T12:05:13.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":108000,"derivative":{"exercise_price":10.38,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":108000},"source":{"system":"sec-edgar","filing":"0001179110-20-007591","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020007591/edgar.xml","form_type":"4"}},{"id":3115611,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CSO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2020-06-10T11:54:36.000Z","date":"2020-06-09","kind":"purchase","acquired":true,"shares":5000,"price":2.9908,"value":14954.0,"ownership":{"direct":true},"balance_after":7357,"source":{"system":"sec-edgar","filing":"0001179110-20-007164","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020007164/edgar.xml","form_type":"4"}},{"id":3483513,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-06-20T20:27:46.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":60000,"derivative":{"exercise_price":2.78,"exercise_date":"2020-06-19","expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001179110-19-007973","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911019007973/edgar.xml","form_type":"4"}},{"id":3891782,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CSO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2018-06-18T12:15:03.000Z","date":"2018-06-15","kind":"purchase","acquired":true,"shares":16500,"price":0.5929,"value":9782.85,"ownership":{"direct":true},"balance_after":35368,"source":{"system":"sec-edgar","filing":"0001179110-18-008669","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911018008669/edgar.xml","form_type":"4"}},{"id":3893269,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-06-15T11:42:16.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":390000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2019 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":390000,"derivative":{"exercise_price":0.6011,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":390000},"source":{"system":"sec-edgar","filing":"0001179110-18-008564","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911018008564/edgar.xml","form_type":"4"}},{"id":4280093,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CSO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-06-16T13:26:58.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":162000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 15, 2018 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":162000,"derivative":{"exercise_price":2.32,"exercise_date":"2018-06-15","expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":162000},"source":{"system":"sec-edgar","filing":"0001179110-17-009154","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911017009154/edgar.xml","form_type":"4"}},{"id":4612401,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35027,"kind":"person","name":"KELER TIBOR","position":1,"cik":"0001429931","reported_name":"KELER TIBOR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CSO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2016-09-06T17:04:17.000Z","date":"2016-09-02","kind":"purchase","acquired":true,"shares":3000,"price":3.32,"value":9960.0,"ownership":{"direct":true},"balance_after":18868,"source":{"system":"sec-edgar","filing":"0001179110-16-029306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911016029306/edgar.xml","form_type":"4"}}]}